Skip to main content

Table 2 AUC0–12 change from day 1

From: The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD

Parameter

BDP/F/G

BDP/F

BDP/F/G – BDP/F

Mean difference

p value

FVC (mls)

545

(414, 676)

339

(208, 470)

206

(54, 359)

0.0116

FEF25–75% (L/s)

0.110

(0.077, 0.143)

0.083

(0.050, 0.117)

0.026

(0.001, 0.051)

0.0395

sGaw (L/s/kPa/L)

0.311

(0.242, 0.381)

0.213

(0.143, 0.282)

0.099

(0.031, 0.167)

0.0101

Raw (kPa/L/s)

 − 0.279

(− 0.323, − 0.236)

 − 0.222

(− 0.266, − 0.179)

 − 0.057

(− 0.077, − 0.037)

 < 0.0001

IC (mls)

257

(135, 379)

260

(138, 382)

3

(− 146, 139)

0.96

FRC (mls)

 − 490

(− 632, − 348)

 − 387

(− 529, − 245)

 − 103

(− 217, 11)

0.07

TLC (mls)

 − 218

(− 319, − 117)

 − 137

(− 238, − 36)

 − 81

(− 196, 34)

0.16

R5–R20 (kPa/L/s)

 − 0.163

(− 0.195, − 0.131)

 − 0.118

(− 0.150, − 0.086)

 − 0.045

(− 0.065, − 0.025)

0.0002

X5 (kPa/L/s)

0.203

(0.155, 0.252)

0.156

(0.108, 0.205)

0.047

(0.025, 0.069)

0.0003

∆X5 (kPa/L/s)

 − 0.137

(− 0.219, − 0.056)

 − 0.095

(− 0.177, − 0.014)

 − 0.042

(− 0.086, 0.002)

0.06

Fres (1/s)

 − 7.201

(− 9.091, − 5.310)

 − 5.005

(− 6.896, − 3.115)

 − 2.195

(− 3.451, − 0.940)

0.0016

AX (kPa/L)

 − 2.911

(− 3.467, − 2.356)

 − 2.205

(− 2.761, − 1.650),

 − 0.706

(− 1.047, − 0.365)

0.0004

  1. Data = mean (95% CI) change in day 5 AUC0–12 from day 1. Treatment difference = BDP/F/G (AUC0–12 change at day 5 from day 1) – BDP/F (AUC0–12 change at day 5 from day 1)